XML 33 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 141,722,000 $ 130,499,000 $ 119,138,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 23,170,000 21,076,000 20,847,000
Depreciation and amortization 21,337,000 22,482,000 21,389,000
Loss on disposal of fixed assets 920,000 1,220,000 1,455,000
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 4,050,000 0 1,000,000
Impairment of Leasehold 1,883,000 0 0
Deferred taxes 5,144,000 (2,512,000) (19,274,000)
Accrued interest on note receivable – related party (40) (47) (55)
Increase (Decrease) in Accrued Interest Receivable, Net 40,000 47,000 54,000
Repayment of Notes Receivable from Related Parties 409,000 409,000 409,000
Deferred rent expense 0 (247,000) 1,455,000
Loss (gain) on sale of marketable securities 5,000 189,000 (5,000)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 0 0 (11,206,000)
Net benefit in connection with reversal of contingent liability partially offset by acceleration of amortization related to Kate Spade license termination (1,868,000) 0 0
Provision for Doubtful Accounts 8,687,000 12,123,000 5,470,000
Changes in:      
Accounts receivable (17,837,000) 4,966,000 22,683,000
Due from factor 24,924,000 (39,959,000) (57,268,000)
Inventories 8,436,000 (26,923,000) 21,135,000
Prepaid expenses, prepaid taxes, deposits and other 9,466,000 14,633,000 2,403,000
Accounts payable and accrued expenses 11,036,000 21,249,000 9,501,000
Accrued incentive compensation (249,000) 828,000 2,507,000
Other liabilities (7,415,000) (5,610,000) 16,350,000
Net cash provided by operating activities 233,780,000 154,376,000 157,935,000
Cash flows from investing activities:      
Purchases of property and equipment (18,311,000) (12,450,000) (14,775,000)
Purchases of marketable securities (67,935,000) (77,262,000) (61,209,000)
Proceeds from Collection of Notes Receivable 0 0 221,000
Maturity/sale of marketable securities 95,671,000 100,777,000 79,141,000
Acquisitions 37,173,000 0 16,795,000
Net cash used in investing activities (27,748,000) 11,065,000 (13,417,000)
Cash flows from financing activities:      
Proceeds from exercise of stock options 6,212,000 13,036,000 16,433,000
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3,248,000 2,577,000 0
Payments to Noncontrolling Interests (1,444,000) (1,183,000) 0
business combinations contingent liability payment 0 (7,000,000) (7,359,000)
Common stock purchased for treasury (101,768,000) (105,924,000) (99,412,000)
Payments of Dividends (48,426,000) (47,316,000) 0
Net cash provided by financing activities (142,178,000) (145,810,000) (90,338,000)
Effect of Exchange Rate on Cash and Cash Equivalents 216,000 (814,000) 919,000
Net decrease in cash and cash equivalents 64,070,000 18,817,000 55,099,000
Cash and cash equivalents – beginning of period 200,031,000 181,214,000 126,115,000
Cash and cash equivalents – end of period 264,101,000 200,031,000 181,214,000
Cash paid during the year for:      
Interest 25,000 36,000 24,000
Income taxes $ 29,552,000 $ 37,105,000 $ 61,979,000